Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial.

Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia.

BACKGROUND Generalized social phobia is common, persistent, and disabling and is often treated with selective serotonin reuptake inhibitor drugs or cognitive behavioral therapy. OBJECTIVE We compared fluoxetine (FLU), comprehensive cognitive behavioral group therapy (CCBT), placebo (PBO), and the combinations of CCBT/FLU and CCBT/PBO. DESIGN Randomized, double-blind, placebo-controlled tria...

A demonstration of the efficacy of two of the components of cognitive therapy for social phobia.

Cognitive-behavioral treatments have demonstrated efficacy in the treatment of social phobia. However, such treatments comprise a complex set of procedures, and there has been little investigation of the effects of individual procedures. The current study investigates the effects of two single session procedures that form part of cognitive therapy for social phobia [Clark, D., Ehlers, A., McMan...

The Effect of The Cognitive Behavioral Therapy and Pharmacotherapy on Infertility Stress:A Randomized Controlled Trial

Efficacy of Cognitive-Behavioral Group Therapy versus Group Hypnotherapy on Brain/Behavioral Systems of Social Phobia Patients

Background & Objective:  Social anxiety disorder, which involves excessive anxiety of social situation due to fear of negative evaluation, is a debilitating disorder that leads to social dysfunction. The purpose of this study is to investigate Efficacy of Cognitive-Behavioral Group Therapy (CBGT) versus Group Hypnotherapy (GHT) on Brain/Behavioral Systems of Social Phobia Patients.  Materials ...

Fluoxetine for the treatment of childhood anxiety disorders.

OBJECTIVE To assess the efficacy and tolerability of fluoxetine for the acute treatment of children and adolescents with generalized anxiety disorder, separation anxiety disorder, and/or social phobia. METHOD Anxious youths (7-17 years old) who had significant functional impairment were randomized to fluoxetine (20 mg/day) (n = 37) or placebo (n = 37) for 12 weeks. RESULTS Fluoxetine was ef...